Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy
about
The sweet trap in tumors: aerobic glycolysis and potential targets for therapyGMP Synthase Is Required for Virulence Factor Production and Infection by Cryptococcus neoformans.Feasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6-diazo-5-oxo-L-norleucine and orlistat in colon cancer.MPI depletion enhances O-GlcNAcylation of p53 and suppresses the Warburg effect.Re-programming tumour cell metabolism to treat cancer: no lone target for lonidamineTargeting cancer cell mitochondria as a therapeutic approach: recent updates.Sensitization of melanoma cells to temozolomide by overexpression of microRNA 203 through direct targeting of glutaminase-mediated glutamine metabolism.Properties and reactivity of nucleic acids relevant to epigenomics, transcriptomics, and therapeutics.Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer.Press-pulse: a novel therapeutic strategy for the metabolic management of cancer.Pheochromocytoma: The First Metabolic Endocrine Cancer.Structure of 6-diazo-5-oxo-norleucine-bound human gamma-glutamyl transpeptidase 1, a novel mechanism of inactivation.Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis.A CTP Synthase Undergoing Stage-Specific Spatial Expression Is Essential for the Survival of the Intracellular Parasite Toxoplasma gondii.We're Not "DON" Yet: Optimal Dosing and Prodrug Delivery ofGlutamine via α-ketoglutarate dehydrogenase provides succinyl-CoA for heme synthesis during erythropoiesis
P2860
Q26766079-8E36577B-0B87-47D9-91A6-3C0BA2518C91Q30397156-18575860-3FD6-4049-B325-C48DF729660AQ33598925-24137A22-565E-40DC-85BF-63F74A7400B8Q33866466-38E5AB0D-F402-4879-91CE-2EE47F17EA78Q36955054-6CA958B0-1656-47A9-9A72-B0506722E7ECQ38668524-2009C2D6-E057-4432-A790-C43CD1713A74Q38700773-F5A3104F-99EE-4708-9403-F69C9D5AA510Q38780402-C357B000-C59F-4B93-BDE6-047EAD235373Q41366826-F4CB12EF-2895-4D8B-87D3-AD39BE89CD14Q41989445-820987B9-C109-4972-ACF7-6E8098700292Q42197171-8B1695D6-7AB1-413D-B41D-28FD79849D7FQ51070949-78946B73-D37A-4796-948A-0EAF3E2FAEDBQ51743298-EBF82C7F-77C8-4452-9BE5-40C258CD1B1BQ52603519-5CAC59C7-E001-4274-B431-16D96B5C1FF0Q57165398-88EF252C-5670-46CF-AC7F-DB949E7B588BQ58761708-3D541B53-938D-4189-BF6C-C152ACCD75BC
P2860
Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Reviving Lonidamine and 6-Diaz ...... n for Metabolic Cancer Therapy
@ast
Reviving Lonidamine and 6-Diaz ...... n for Metabolic Cancer Therapy
@en
Reviving Lonidamine and 6-Diaz ...... n for Metabolic Cancer Therapy
@nl
type
label
Reviving Lonidamine and 6-Diaz ...... n for Metabolic Cancer Therapy
@ast
Reviving Lonidamine and 6-Diaz ...... n for Metabolic Cancer Therapy
@en
Reviving Lonidamine and 6-Diaz ...... n for Metabolic Cancer Therapy
@nl
prefLabel
Reviving Lonidamine and 6-Diaz ...... n for Metabolic Cancer Therapy
@ast
Reviving Lonidamine and 6-Diaz ...... n for Metabolic Cancer Therapy
@en
Reviving Lonidamine and 6-Diaz ...... n for Metabolic Cancer Therapy
@nl
P2860
P921
P3181
P356
P1476
Reviving Lonidamine and 6-Diaz ...... n for Metabolic Cancer Therapy
@en
P2093
Alfonso Dueñas-González
Diana Cervantes-Madrid
P2860
P304
P3181
P356
10.1155/2015/690492
P407
P50
P5008
P577
2015-09-06T00:00:00Z